Introduction: The study details the experiences of Medicare, Medicaid and privately insured patients with diabetes in the United States by focusing on how these distinct populations perceive their disease and manage their treatment.
Results: Patients
with Medicaid-based insurance face significant differences in diagnosis, treatment and intensity of their diabetes as compared to their Medicare and privately insured counterparts. Medicaid patients develop diabetes at an earlier age with an increased level of severity, and face significant socioeconomic concerns. Medicaid patients also have different health information seeking preferences than their counterparts, impacted by technology use patterns and education preferences. All groups report challenges in paying for their diabetes care, though cost-sharing requirements are relatively low.
Conclusions: Significant variation in experience between Medicaid, Medicare, and privately insured patients can inform disease management and patient engagement strategies. Payers, clinicians and public health agencies can leverage these findings to design initiatives more effectively and understand how intergroup variability impacts program uptake and disease outcomes.
Electronic supplementary material The online version of this article (doi:10.1007/s13300-015-0109-z) contains supplementary material, which is available to authorized users.
INTRODUCTION
Diabetes mellitus is currently the seventh leading cause of mortality in the United States, and represents a significant economic and public health burden [1] . Presently, there are 21 million Americans diagnosed with diabetes, with approximately 8.1 million still undiagnosed and over 79 million with at-risk blood glucose levels [1, 2] . Diabetes is associated with a number of severe comorbidities, including visual impairment, lower extremity conditions/amputation, neuropathy, renal disease and cardiovascular disease [2] . With this rapidly growing patient base and high rates of severe comorbidities, diabetes is a major clinical and economic concern for payers and employers. In April 2013, the American Diabetes Association (ADA) released a comprehensive examination of costs in the US directly attributable to diabetes. In this report, the estimated annual cost of diabetes in the US is $245 billion, with $176 billion in direct medical costs and $69 billion in reduced productivity [3] . When examined over a 5-year period, direct medical costs of diabetes care have increased more than 30% over the rate of inflation, a number directly attributable to increased prevalence in the U.S. [3] . Previous studies have shown that this expenditure is attributable to uncontrolled diabetes, especially within the Medicare and Medicaid populations [3] [4] [5] .
The [6, 7] . The ADA also recommends regular diabetes selfmanagement education (DSME) by accredited facilities held to strict patient curriculum standards [8] . Adherence to these guidelines, particularly those concerning HbA1c and blood lipid tests, has been previously proven to contribute directly to improved long-term clinical outcomes in people with diabetes [9] .
Despite these efforts, a vast discrepancy in adherence to these standards exists across different insurance types, races/ethnicities, and socioeconomic statuses (SES), resulting in many Americans with diabetes not receiving the appropriate care or education [10, 11] . For example, there is variability in access to health care providers (HCP), DSME, prescription coverage; as well as in the levels of adherence to medication across different racial groups, with black and Hispanic patients having lowest access and levels of adherence [8, 12, 13] . The discrepancies in diabetes care provision across socio-demographic groups are exacerbated by a higher disease prevalence among black and Hispanic patients than in non-Hispanic white patients: 13.2% of non-Hispanic black patients and 11.9% of Hispanic patients have diabetes, both rates significantly higher than non-Hispanic white patients at 7.1% [2] . However, racial disparities alone do not explain differential outcomes for people with diabetes.
Recent studies have found that access to insurance coverage is the most powerful determinant of proper care for people with diabetes [11, 14] . Insured patients have greater access to clinicians, treatment and education generally, but little is known about the different attitudes and behaviors of people with diabetes by payer subgroup. Specifically, do Medicaid, Medicare, and privately insured people with diabetes differ significantly in their journey, access to information, use of internet education, overall patient experience of their disease, or cost burden related to their disease?
As adherence and poor outcomes remains a critical issue for people with diabetes across all payer subgroups, more needs to be understood in how these populations are both consistent and differ. [17] [18] [19] . Studies have shown a direct correlation between the use of information technology systems for diabetes self-management and improved metrics of overall health [20] . However, the applications available today have only been shown effective as supplementary support to traditional DSME and do not yet provide a comprehensive set of tools for self-management [21] . Furthermore, these solutions often require access to the internet and smartphones, a premise which may work fine for most privately insured patients but because elderly patients and those with lower SES have lower utilization rates, could cause access hurdles or lead to diminished use [22] .
Putting these factors together, questions remain as to how differently insured populations compare to each other in terms of disease experience and types of disease management approaches that are likely to succeed within each group. This study examines Medicaid, Medicare and Privately insured populations of diabetes patients to elucidate the key differences between them and how this information could inform future program and policy making.
METHODS

Patient Selection
The sample for the telephone component was (Table 1) .
Access to Information
According to the study findings, Medicaid and
Medicare patients have very different access to and use of information sources as compared to patients with private insurance. Medicaid patients have the lowest rate of internet access, either at home or at work, with 58.1%
versus Medicare with 66.3% (Fig. 1 (Fig. 2b) .
The burden of disease and associated comorbidities were significantly higher within Medicare and Medicaid than privately insured patients, reporting more than 7 other health problems in addition to diabetes on average (private: \5 This is due to the fact that patients in our study were treating 2-3 comorbidities outside of their diabetes with prescription medication. Alleviating or addressing this concern, across groups, should be considered a priority as patients report the significant impact on treatment adherence and other positive health behaviors such as taking medicine or visiting their provider [9] .
While people with diabetes across payer groups' document concerns related to the cost of their disease and its management, the payers themselves are struggling to ensure their patients are better managed, adhere to treatment protocols and engage in ongoing education about their illness to support positive health behaviors. Despite providing coverage for DSME, we found that all three patient groups exhibited low utilization rates.
One approach, by payers, has been to leverage digital health monitoring tools to supplement engagement and disease management of people technologies enable wide deployment of application-based tools [17, 19, 20] . However, these and other technology based solutions may not be adopted by patients most in need; in our study those most prevalent in the Medicaid population.
Medicaid Covered Diabetes Patients
The Medicaid group report higher rates of disability, depression, and comorbidities than the other two groups. Additionally, they report having economic challenges, low use of internet-based education systems, and widespread feelings of hopelessness related to improving their disease experience. These factors drive non-adherence to treatment regimens and result in poorer outcomes. Disease management and patient engagement strategies targeting these patients, those most in need and perhaps the most complex, need to take these characteristics into account as solutions are developed. If those patients most in need have low smartphone ownership and internet use for health information, then many digital health and wellness activities targeting people with diabetes may not be reaching their target populations. Additionally, with many patients experiencing comorbidities with their diabetes, solutions will need to provide support for the whole patient experience rather than just the component associated with diabetes management.
Medicare Covered Diabetes Patients
The Medicare group is generally older, finds change more difficult, uses the internet for information sporadically, and has higher comorbidities than privately insured patients. Additionally, being younger, employed, and less likely to have comorbidities allow targeted initiatives to focus on core concerns related to the disease and life experience of the patientsleveraging internet-based education models and employer support systems. While privately insured patients are likely to have more resources than their Medicaid and Medicare counterparts, they still report feelings of concern related to affording their diabetes medication and treatments.
This data should be interpreted with the following limitations in mind. This study reviews patient reported data, without examination of medical record or claims data.
As a result, the accuracy of the data is limited by the patient's memory and willingness to provide information. Additionally, this study was only performed in English and Spanish, and therefore only includes the views of patients proficient in one of those two languages. 
